Skip to main content

Table 3 Univariate and multivariate analyses to determine predictors of hospitalization in pediatric patients with asthma exacerbation

From: Can eosinophilia and neutrophil–lymphocyte ratio predict hospitalization in asthma exacerbation?

  Univariate analysis Multivariate analysis
Crude OR (95% CI) P Adjusted OR (95% CI) P
Gender, female 1.87 (1.07–3.28) 0.029 1.96 (0.98–3.91) 0.057
Not using an asthma action plan 2.15 (1.2–3.84) 0.01 2.22 (1.09–4.49) 0.027
Atopy status 1.13 (0.63–2.02) 0.674
Cause of the exacerbation
 Infection versus non-infectious cause 1.53 (0.85–2.73) 0.153 1.65 (0.81–3.36) 0.169
 Allergen versus non-allergenic cause 0.58 (0.19–1.72) 0.323
 Non-adherence to prescribed therapy versus adherence 0.87 (0.45–1.68) 0.671
Duration of asthma
 < 1 year versus > 1 year 0.69 (0.37–1.27) 0.233
 1–2 years versus < 1 year and > 2 years 1.04 (0.57–1.87) 0.904
 > 2 years versus < 2 years 0.68 (0.34–1.37) 0.28
Biomarkers
 Blood eosinophil count \(\ge\) 298 versus < 298 8.87 (4.73–16.62) < 0.001 8.79 (4.44–17.4) < 0.001
 NLR \(\ge\) 2.52 versus < 2.52 3.04 (1.72–5.35) < 0.001 2.13 (1.09–4.14) 0.027